Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 64.35M | € 60.82M | € 75.03M | € 80.31M | € 56.45M |
Total Assets | € 528.85M | € 498.43M | € 506.36M | € 488.55M | € 477.77M |
Total Debt | € 79.58M | € 68.76M | € 93.02M | € 85.42M | € 113.39M |
Net Debt | € 15.22M | € 7.94M | € 17.99M | € 5.10M | € 56.95M |
Total Liabilities | € 203.71M | € 159.84M | € 187.27M | € 169.06M | € 178.01M |
Stockholders Equity | € 325.08M | € 338.69M | € 319.15M | € 319.57M | € 299.80M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |